«
»

Top

Prostate cancer breakthrough could lead to new diagnostic tests and treatments

Published 1 Aug 2016

Prostate cancer breakthrough could lead to new diagnostic tests and treatments
Prostate cancer patients have been offered hope after scientists at Newcastle University, UK, have identified a new group of molecules that could be targeted to slow tumour growth.
 
Experts used an advanced screening technique which found hundreds of genes were affected by the male hormone testosterone. It is believed this could lead to new diagnostic tests and treatments.
 
Among the 700 genes identified was an important set that add sugar groups -- known as glycans -- to the surface of prostate cancer cells. This group has never been investigated before.
 
Results of the research, published in EBioMedicine, suggest that testosterone changes glycans to make cancer cells more likely to survive, grow and spread to other parts of the body.
 
Scientists say there is the potential to target these glycans which could stop the growth and spread of tumours and save lives.
 
Dr Jennifer Munkley, Research Associate at the Institute of Genetic Medicine, Newcastle University, co-led the three-year research project with Professor David Elliott.
 
She said: "Our findings are very significant for future treatments as they identify a new group of molecules in prostate cancer which could be targeted therapeutically.
 
"Now we have identified these glycans we will be able to develop strategies to inhibit them and help patients with this condition.
 
"Treatments targeting glycan sugar groups have been developed for other types of the illness, such as breast cancer. Our results mean these treatments could also be used for prostate cancer."
 
Glycans have the potential to be used as part of a diagnostic test to help doctors decide which prostate cancers need treatment.
 
One in eight will be diagnosed with the condition. It is the most common cancer in UK males, and there is a need to identify how the disease progresses and for treatment options to be established.
 
Researchers at Newcastle University used a technique, called RNA-sequencing, to identify the new set of genes that are important.
 
The genes identified may provide novel ways the disease can be monitored in patients to predict the most aggressive prostate cancers that need to be treated.
 
The research was funded in partnership between Prostate Cancer UK and the Movember Foundation.
 
Simon Grieveson, Head of Research Funding at Prostate Cancer UK, said: "There's a desperate need for more treatments for men with advanced prostate cancer, who currently have too few options available to them.
 
"However, in order to develop new, effective treatments, we need to understand more about the genetic makeup of aggressive prostate cancers and identify what makes them tick.
 
"This promising research has unearthed a new group of genes which could play a part in cancer cell survival and development, and could pave the way for new treatments in the future.
 
"Although this work is still in its infancy, and there is a long way to go before we could have a potential new treatment, we will be watching its progression with great interest."
 
Dr Munkley has been awarded a Newcastle University Faculty of Medical Sciences Fellowship to continue her research.
 
As each prostate tumour is unique, future studies will look at how to use glycans as therapeutic targets in personalised treatment.
 
Case study
 
One man who knows first-hand the importance of this research is David Forrester, who was diagnosed with prostate cancer four years ago.
 
The 62-year-old experienced some episodes of what he thought to be urinary infections. His brother had been diagnosed with the illness in 2004 and, therefore, Mr Forrester was monitored by doctors.
 
He had annual PSA tests -- a blood test that can detect the early signs of an enlarged prostate -- and his PAS doubled in a short space of time. Mr Forrester was referred to a urologist and underwent a biopsy which confirmed he had prostate cancer.
 
As a former operating theatre manager, the grandfather-of-three decided to have surgery to remove his prostate. Although he did experience side-effects, he has recovered well and is enjoying life.
 
Mr Forrester, of West Denton, Newcastle, said: "It is absolutely vital that research is done into prostate cancer and experts gain as good an understanding of the condition as possible.
 
"With two sons and two grandsons, who are at higher risk of developing the disease, I am especially interested in this research.
 
"The results of this study offers hope to patients affected by prostate cancer and their families that improved diagnostics and treatment options will be developed in the years ahead.
 
"It is exciting that Newcastle University is leading the way and it shows what world-class research is going on."

3 comments


dennit
on 05/10/2016

Appro 3 years ago my PSA was monitored as it went from 4.9 to over 11.I was told that I could have an enlarged prostrate so my PSA would be monitored and I was referred to theUrology dept in Folkestone,KENT.For about the next year my PSA averaged 11.9.,but was offered a biopsy,which I had.The news was not good,as I was told I had prostrate cancer,grade 6(which is the lowest level).On seeing the specialist (Mr. Streeter) I was offered to take a new biopsy at Maidstone hospital,as they have a machine which inserts 32 needles into your prostrate.The outcome was amazing as I was told I now do not have prostate cancer,they said that in the biopsy one of the needles had probally extracted the minute cancer.I was still to have my PSA done every 3 months which slowly went into reverse with the readings ,then some 15 months later my PSA has shot up to 16.3,now I am waiting to hear what direction we go in.

I must say before the 2nd biopsy I was having slight problems getting an erection,after the 2nd biopsy I failed to get an erection at all until 2 months ago I managed 2 on the trot.

All medications have been given to me without success so again I am now waiting?

They say after the 2nd biopsy it probaly damaged a nerve which can take up to and in some cases over 2 years to right itself.

I do not know if this helps anyone but other experiences would be welcome.


avatar
Unregistered member
on 10/10/2016

In 1999 I had what I suspected was a urology problem - getting up too often during the night to urinate - I saw a consultant urologist and was diagnosed with a PSA of 17, against the average mans 3.5. which confirmed, I was told, that I had prostate cancer.  I was given a choice of three treatments, radiology, removal of the prostate and a radical orchidectomy which I opted for. After the operation I was informed "that will give you 5 years". Here I am 16 years later. My PSA reading post-op was 0.25. As expected this has slowly crept up to 2.6.  If my case helps anyone to make a decision then I shall be very pleased


SeanDD
on 24/10/2016

In January 2014, I had a hip/glut pain that I could not get rid of with Physio (I exercise a lot and the soreness was because of this training). I decided for a hip MRI in April which was clear but they noticed abnormality with my Prostate. I had no symptoms and my PSA when tested was 0.98. After much discussion I went for a biopsy in Oct 2014, results showed I had Prostate cancer, Gleason 6 (lowest form). I was given several options, surgery, Radiotherapy, Active monitoring, Bracheatherapy. After much deliberation I decided for radical Prostecthamey  in April 2015. I am totally clear now of cancer as it was confined to the prostate, interestingly when they examined the prostate after removal they only found cancer in one side, whereas the biopsy had found it in both sides. Surgeon said that biopsy needle may have removed the cancer cells on one side. I still have some ED, but it has improved.

You will also like

World Cancer Day: Facts and Insights!

Prostate cancer

World Cancer Day: Facts and Insights!

Read the article
Telling patients to 'fight' cancer puts them under pressure

Prostate cancer

Telling patients to 'fight' cancer puts them under pressure

Read the article
Lung cancer destroyed with tea leaf nanoparticles

Prostate cancer

Lung cancer destroyed with tea leaf nanoparticles

Read the article
Prostate cancer: the importance of PSA testing and positivity

Prostate cancer

Prostate cancer: the importance of PSA testing and positivity

See the testimonial

Most commented discussions

Fact sheet